Abstract
Prostatic carcinoma has familial incidence. It has a relatively high frequency in the black population in U.S.A. and a relatively low frequency amongst Jews and Japanese. Mortality from prostatic carcinoma constitutes the second most frequent cause of deaths from cancer in the male population in the U.S.A. Extensive investigations are being conducted by the National Prostatic Cancer Project in the U.S.A. to determine if a high-risk group can be further identified.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Ablin RJ: Serum antibody in patients with prostatic cancer. Br J Urol 48: 355, 1976.
Ablin RJ et al.: Evaluation of cellular immunologic responsiveness in the clinical management of patients with prostatic cancer. I. Thymic-dependent lymphocytic blastogenesis. Urol Int 31: 374, 1976.
Ablin RJ, et al.: Evaluation of cellular immunologic responsiveness in the clinical management of patients with prostatic cancer. III. Inhibition of leucocyte migration. Urol Int 31: 444, 1976.
Ablin RJ, et al.: Evaluation of cellular immunologic responsiveness in the clinical management of patients with prostatic cancer. IV. Leucocyte adherence inhibition. Urol Int 31: 459, 1976.
Ablin RJ, et al.: Immunostaging of patients with prostatic cancer: correlation of immunostage and clinical stage. An interim report. Curr Ther Res 20: 674, 1976.
Ablin RJ, et al.: Serum proteins in prostatic cancer. V. Alterations in immunoglobublins and clinical responsiveness following cryoprostatectomy. Urol Int 32: 56, 1977.
Ablin RJ, et al.: Serum proteins in prostatic cancer. VI. Reduction of the suppressive (blocking) properties of serum on in vitro parameters of cell-mediated immunologic responsiveness following cryosurgery. Urol Int 32: 65, 1977.
Ablin RJ, et al.: Leukocyte adherence inhibition and immunoreactivity in prostatic cancer. I. Identification of antitumour cell-mediated immunity and ‘blocking’ factor. Eur J Cancer 13: 699, 1977.
Ablin RJ, et al.: Inhibition of leukocyte migration by extracts of malignant prostatic tissue and correlation of degree of in vitro sensitization to clinical responsiveness in prostatic cancer patients. Urology 11: 289, 1978.
Abrams PH: A double-blind trial of the effects of candicidin on patients with benign prostatic hypertrophy. Br J Urol 49: 67, 1977.
Abrams PH: Prostatism and prostatectomy: the value of urine flow rate measurement in the preoperative assessment for operation. J Urol 117: 70, 1977.
Ackerman R, et al.: Retrospective analysis of 645 simultaneous perineal punch biopsies and transrectal aspiration biopsies for diagnosis of prostatic carcinoma. Eur Urol 3: 29, 1977.
Addonizio JC, et al.: Perineal seeding of prostatic carcinoma after needle biopsy. Urology 8: 513, 1976.
Adolphs HD, et al.: Correlation between tumor stage, tumor grade, and immunocompetence in patients with carcinoma of the bladder and prostate. Eur Urol 3: 23, 1977.
Agarwal RA, et al.: Prostatic carcinoma: castration alters the metabolism of catecholamine and 5-hydroxytrayptamine. Gen Pharmacol 8: 197, 1977.
Airhart RA, et al.: Flutamide therapy for carcinoma of the prostate. South Med J 71: 798, 1978.
Alsheik HI, et al.: The effect of transurethral resection of the prostate on lymphocyte response in patients with prostatic cancer. J Urol 118: 1022, 1977.
Altwein JE: Radiotherapy, hormone therapy and palliative therapy of prostatic carcinomas. Med Welt 29: 1210, 1978.
Anderson JT, et al.: Detrusor and urethral dysfunction of prostatic hypertrophy. Br J Urol 48: 493, 1976.
Andersen JT, et al.: Combined cystometric, sphincter electromyographic and uroflowmetric studies before and after transurethral resection of the prostate. J Urol 116: 786, 1976.
Anderson RU, et al.: Physical and chemical determinations of prostatic secretion in benign hyperplasia, prostatitis, and adenocarcinoma. Invest Urol 14: 137, 1976.
Andersson L, et al.: Estramustine phosphate therapy in carcinoma of the prostate. Recent Results Cancer Res 60: 73, 1977.
Anikwe RM: Correlations between clinical findings and urinary flow rate in benign prostatic hypertrophy. Int Surg 61: 392, 1976.
Anikwe RM: The effect of a 6FG urethral catheter on urinary flow in benign prostatic hypertrophy. Int Surg 61: 417, 1976.
Anikwe RM: Patterns of urinary flow in benign prostatic hypertrophy. Int Surg 61: 433, 1976.
Anikwe RM: Bladder wall tension in benign prostatic hypertrophy. Invest Urol 14: 452, 1977.
Anikwe RM: Effect of estrogen therapy on metastatic carcinoma of the prostate. Int Surg 62: 532, 1977.
Anikwe RM: Urodynamics in benign prostatic hypertrophy. Br J Urol 50: 20, 1978,
Arvis G: Difficulties of treatment in the chronic prostatitis. Prog Clin Biol Res 6: 417, 1976.
Arya SK, et al.: RNA tumor virus-like activities in human prostate; possible novel pharmacologic approaches. Cancer Treat Rep 61: 113, 1977.
Attah EB, et al.: Atypical stromal hyperplasia of the prostate gland. Am J Clin Pathol 67: 324, 1977.
Baba S, et al.: Antiandrogenic effects of spironolactone: hormonal and ultrastructural studies in dogs and men. J Urol 119: 375, 1978.
Bagshaw MA, et al.: Evaluation of extended-field radiotherapy for prostatic neoplasm: 1976 progress report. Cancer Treat Rep 61: 297, 1977.
Bandhauer K, et al.: Evaluation of prostatic cytology in primary diagnosis and clinical course of prostatic carcinoma. Prog Glin Biol Res 6: 329, 1976.
Baranowska B, et al.: Rose of hormonal factors in the pathogenesis of prostatic hypertrophy. Pol Tyg Lek 32: 251, 1977.
Bard DR, et al.: The influence of oestradiol on the metabolism of androgens by human prostatic tissue. J Endocrinol 74: 1, 1977.
Bartsch G, et al.: Possibilities of the quantitative structural analysis of prostate biopsies. Bull Schweiz Akad Med Wiss 33: 99 1977.
Bartsch W, et al.: Sex hormone binding globulin binding capacity, testosterone, 5-alpha-dihydrotestosterone, oestradiol and prolactin in plasma of patients with prostatic carcinoma under various types of hormonal treatment. Acta Endocrinol (Kbh) 85: 650, 1977.
Bartsch W, et al.: Hormone blood levels in patients with prostatic carcinoma and their relation to the type of carcinoma growth differentiation. Eur Urol 3: 47, 1977.
Bartsch G: Stereology, a new quantitative morphological approach to study prostatic function and disease. Eur Urol 3: 85, 1977.
Barzell W, et al.: Prostatic adenocarcinoma: relationship of grade and local extent to the pattern of metastases. J Urol 118: 278, 1977.
Bashirelahi N, et al.: Specific binding protein for 17 betaestradiol in prostate with adenocarcinoma. Urology 8: 552, 1976.
Baumueller A, et al.: Rosamicin - a new drug for the treatment of bacterial prostatitis. Antimicrob Agents Chemother 12: 240, 1977.
Beck PH, et al.: Plasma testosterone in patients receiving diethylstilbestrol. Urology 11: 157, 1978.
Belville WD, et al.: Bone marrow acid phosphatase by radioimmunoassay. Cancer 41: 2286, 1978.
Benson RC Jr.: Treatment of prostatic carcinoma with estramustine phosphate (Estracyt). Wis Med J 75: 89, 1976.
Benson RC Jr., et al.: Primary yolc-sac (endodermal sinus) tumor of the prostate. Cancer 41: 1395, 1978.
Bhatti RA, et al.: Responsiveness of lymphocytes to soluble extracts of prostatic tumors and abrogation by serum-blocking factor(s). Urology 9: 314, 1977.
Bioorneklett A, et al.: Bone marrow metastases from prostatic cancer-marked cytolytic effect after only a few days of treatment with diethylstilbestrol. Scand J Haematol 17: 227, 1976.
Birkhead BM: Definitive radiotherapy of prostatic cancer: a progress report. J Ky Med Assoc 76: 118, 1978.
Bishop D, et al.: A study of transrectal aspiration biopsies of the prostate with particular regard to prognostic evaluation. J Urol 117: 313, 1977.
Bishop MC, et al.: Urine hydroxyproline excretion - a marker of bone metastases in prostatic carcinoma. Br J Urol 49: 711, 1977.
Bissada NK: Accuracy of transurethral resection of the prostate versus transrectal needle biopsy in the diagnosis of prostatic carcinoma. J Urol 18: 61, 1977.
Bissada NK, et al.: Prostatic mycosis: nonsurgical diagnosis and management. Urology 9: 327, 1977.
Bissada NK, et al.: Factors affecting accuracy and morbidity in transrectal biopsy of the prostate. Surg Gynecol Obstet 145: 869, 1977.
Block NL, et al.: Chemotherapy of the transplantable adenocarcinoma (R-3327) of the Copenhagen rat. Oncology 34: 110, 1977.
Blomback M, et al.: Blood coagulation studies in patients with advanced carcinoma of the prostate treated with 2,6-cisdiphenylhexamethylcyclotetrasiloxane or estramustine-17-phosphate. Urol Res 6: 95, 1978.
Blomgren H, et al.: Reductions of responder and stimulator capacities of peripheral lymphoid cells in the mixed lymphocyte culture following external radiotherapy. Int J Radiat Oncol Biol Phys 2: 297, 1977.
Boehme WM, et al.: Lack of usefulness of bone marrow enzymes and calcium in staging patients with prostatic cancer. Cancer 41: 1433, 1978.
Boileau M, et al.: The effect of human serum on 3H-thymidine incorporation in human prostate tumors in tissue culture. J Urol 119: 779, 1978.
Bonard M, et al.: Placebo-controlled double-blind study in human benign obstructive prostatic hypertrophy with flutamide. Eur Urol 2: 24, 1976.
Boxer RJ: Adenocarcinoma of the prostate gland. Urol Surv 27: 75, 1977.
Brannen GE, et al.: Tumor specific immunity in patients with prostatic adenocarcinoma or benign prostatic hyperplasia. Cancer Treat Rep 61: 211, 1977.
Brecher ML, et al.: Nonsurgical treatment of pelvic rhabdomyosarcoma: a case report. J Surg Oncol 9: 601, 1977.
Breslow N, et al.: Latent carcinoma of prostate of autopsy in seven areas. Int J Cancer 20: 680, 1977.
Broder LE, et al.: Placental proteins and their subunits as tumor markers prostatic carcinoma. Cancer 40: 211, 1977.
Bruce AW, et al.: Carcinoma of the prostate: a critical look at staging. J Urol 117: 319, 1977.
Bruckman JE, et al.: Re: radical prostatectomy for carcinoma of the prostate: 1951–1976. A review of 329 patients. J Urol 118: 692, 1977.
Buck AC, et al.: Follow-up of prostate carcinoma with serial bone scanning using cyclotron-produced 18-flourine. Recent Results Cancer Res 60: 91, 1977.
Buell GV, et al.: Chemotherapy trial with comp-F regimen in advanced adenocarcinoma of prostate. Urology 11: 247, 1978.
Burke WR, et al.: Seven year survival of child with rhabdomyosarcoma of prostate. Urology 8: 357, 1976.
Butz GW, et al.: Response to chemically induced prostatic tumors in rats to stilbestrol and orchiectomy. Surg Forum 27: 590, 1976.
Cadman E, et al.: Chemotherapy of skeletal metastases. Int J Radiat Oncol Biol Phys 1: 1211, 1976.
Caine M, et al.: The treatment of benign prostatic hypertrophy with flutamide (SCH: 13521): a placebo-controlled study. J Urol 114: 564, 1975.
Caine M, et al.: The use of alpha-adrenergic blockers in benign prostatic obstruction. Br J Urol 48: 255, 1976.
Catalona WJ, et al.: Surgical considerations in treatment of intraductal carcinoma of the prostate. J Urol 120: 259, 1978.
Catalona WJ, et al.: Carcinoma of the prostate: a review. J Urol 119: 1, 1978.
Catane R, et al.: Oral estramustine phosphate. Prolonged therapy for advanced carcinoma of prostate. NY State J Med 76: 1978, 1976.
Catane R, et al.: Disappearance of osteoblastic metastases in prostatic carcinoma following estramustine therapy. JAMA 237: 2471, 1977.
Catane R, et al.: Combined therapy of advance prostatic carcinoma with estramustine and prednimustine. J Urol 117: 332, 1977.
Catane R, et al.: Indium choride bone-marrow scanning in advanced prostatic carcinoma. NY State J Med 77: 1413, 237: 2471, 1977.
Catane R, et al.: Combined therapy of advanced prostatic cancer. Br J Urol 50: 29, 1978.
Cauda F, et al.: Retrograde urethrography with double contrast medium in the differential diagnosis of prostatic adenoma and carcinoma. Minerva Urol 29: 53, 1977.
Celesk RA, et al.: Ultrastructural cytology of prostate carcinoma cells from Wistar rats. Invest Urol 14: 95, 1977.
Chan SY, et al.: In vitro effects of lipoprotein-associated cytotoxic factor on rat prostate adenocarcinoma cells. Cancer Res 38: 2956, 1978.
Chica G, et al.: Mucinous adenocarcinoma of the prostate. J Urol 118: 124, 1977
Chisholm GD, et al.: The treatment of oestrogen-escaped carcinoma of the prostate with estramustine phosphate. Br J Urol 49: 717, 1977.
Chopra DP, et al.: Prevention and Control beta-Retinoic acid inhibits and reverses testosterone-induced hyperplasia in mouse prostate organ cultures. Nature 265: 339, 1977.
Christoffersen JC, et al.: Prostatic desiccation used in poor-risk patients with benign and malignant prostatic obstruction. Eur Urol 2: 229, 1976.
Chu TM: Serum acid phosphohydrolase (phosphatase) and ribonuclease in diagnosis of prostatic cancer. Antibiot Chemother 22: 98, 1978.
Chu TM, et al.: Immunochemical detection of serum prostatic acid phosphatase. Methodology and clinical evaluation. Invest Urol 15: 319, 1978.
Chung LS, et al.: Androgen glucuronide. II. Differences in its formation by human normal and benign hyperplastic prostates. Invest Urol 15: 385, 1978.
Claflin AJ, et al.: The Dunning 0327 prostate adenocarcinoma in the Fisher-Copenhagen FI rat: a useful model for immunological studies. Oncology 34: 105, 1977.
Claflin AJ, et al.: Inhibition of growth and guanylate cyclase activity of an undifferentiated prostate adenocarcinoma by an extract of the balsam pear. Natl Acad Sci USA 75: 989, 1978.
Clark P, et al.: Subcapsular orchidectomy for carcinoma of the prostate. Br J Urol 49: 419, 1977.
Collier D, et al.: Doxorubicin hydrochloride, cyclophosphamide, and 5-fluorouracil combination in advanced prostate and transitional cell carcinoma. Urology 8: 459, 1976.
Court B, et al.: Interstitial radiation therapy of cancer of the prostate using iridium 192 wires. Cancer Treat Rep 61: 329, 1977.
Cox JE, et al.: The significance of needle biopsy after irradiation for stage C adenocarcinoma of the prostate. Cancer 40: 156, 1977.
Crisp J: Random bone marrow biopsy in the staging of carcinoma of the prostate. Br J Urol 48: 165, 1976.
Dajani YF, et al.: Leukemic infiltration of the prostate: a case study and clinicopathological review. Cancer 38: 2442, 1976.
Denis L, et al.: Radical prostatectomy: choice or chance. Eur Urol 4: 18, 1978.
Denis L, et al.: Progestogens in prostatic cancer. Eur Urol 4: 162, 1978.
Dennis M, et al.: Plasma sex hormone-binding globulin binding capacity in benign prostatic hypertrophy and prostatic carcinoma: comparison with an age dependent rise in normal human males. Endocrinol (Kbh) 84: 207, 1977.
Dermer GB: Basal cell proliferation in benign prostatic hyperplasia. Cancer 41: 1857, 1978.
Deutsch E: Disseminated intravascular coagulation in prostatic disease. Prog Clin Biol Res 6: 313, 1976.
DeWys WD, et al.: Comparative trial of adriamycin and 5-fluorouracil in advanced prostatic cancer: progress report Cancer Treat Rep 61: 325. 1977.
Dhom G: Pathology and classification of prostatic carcinoma. J Prog Clin Biol Res 6: 111, 1976.
Dhom G: Classification and grading of prostatic carcinoma. Recent Results Cancer Res 60: 14, 1977.
Dias R, et al.: Survival of patients with unsuspected prostatic carcinoma after open prostatectomy. Urology 11: 599, 1978.
Dilley WG, et al.: Hormone response of benign hyperplastic prostate tissue in organ culture. Invest Urol 15: 83, 1977.
Dmochowski L, et al.: Search for oncogenic viruses in human prostate cancer. Cancer Treat Rep 61: 119, 1977.
Donohue RE, et al.: Pelvic lymphadenectomy in stage A prostatic cancer. Urology 9: 273, 1977.
Dounis A.: Extremely high serum acid phosphatase level in carcinoma of prostate. J Urol 118: 500, 1977.
Drach GW: Sexuality and prostatitis: a hypothesis. J Am Vener Dis Assoc 3: 87, 1976.
Dunzendorfer U, et al.: Septicemic states and infections after transurethral resection and adenomectomy of the prostate. J Urol Nephrol 82 Suppl 2: 119, 1976.
Dunzendorfer U, et al.: Altered polyamine profiles in prostatic hyperplasia and in kidney tumors. Cancer Res 38: 2321, 1978.
Eagan RT, et al.: Adriamycin (NSC-123127) versus 5-fluorouracil (NSC-19893) and cyclophosphamide (NSC-26271) in the treatment of metastatic prostate cancer. Cancer Treat Rep 60: 115, 1976.
Earnster VL, et al.: Race, socioeconomic status, and prostatic cancer. Cancer Treat Rep 61: 187, 1977.
Elhilali MM, et al.: Urodynamic evaluation of prostatic obstructions. Union Med Can 106: 000, 1977.
Elliott GB, et al: Latent carcinoma of the prostate in a 24 year old man receiving cyclophosphamide and azathioprine. Can Med Assoc J 116: 651, 1977.
Epstein NA: Prostatic biopsy. A morphologic correlation of aspiration cytology with needle biopsy histology. Cancer 28: 2078, 1976.
Epstein NA: Prostatic carcinoma. Correlation of histologic features of prognostic value with cytomorphology. Cancer 38: 2071, 1976.
Epstein NA: Primary papillary carcinoma of the prostate: report of a histopathologic, cytologic and electron microscopic study on one case. Acta Cytol 21: 543, 1977.
Ernster VL, et al.: Prostatic cancer: mortality and incidence rates by race and social class. Am J Epidemiol 107: 311, 1978.
Ernster VL, et al.: Cohort mortality for prostatic cancer among United States nonwhites. Science 200: 1165, 1978.
Evans CM, et al.: Immunological tests in carcinoma of the prostate. Proc R Soc Med 70: 417, 1977.
Fair WR, et al.: The prostatic antibacterial factor: identity and significance. Prog Clin Biol Res 6: 383, 1976.
Farnsworth WE, et al.: Prolactin and prostate cancer. Urology 10: 33, 1977.
Feld RD, et al.: Presence of creatine kinase BB isoenzyme in some patients with prostatic carcinoma. Clin Chem 23: 1930, 1977.
Fingerhut B, et al.: An animal model for the study of prostatic adenocarcinoma. Invest Urol 15: 42, 1977.
Firusian N, et al.: Results of 89 strontium therapy in patients with carcinoma of the prostate and incurable pain from bone metastases: a preliminary report. J Urol 116: 764, 1976.
Forman WB, et al.: Transurethral resection in a patient with a dysfibrinogen: fibrinogen Cleveland I. J Urol 118: 885, 1977.
Forshell GP, et al.: The absorption metabolism, and excretion of Estracyt in patients with prostatic cancer. Invest Urol 14: 128, 1976.
Fossa SD, et al.: Hormone changes in patients with prostatic carcinoma during treatment with estramustine phosphate. J Urol 118: 1013, 1977.
Foti AG, et al.: Isozymes of acid phosphatase in normal and cancerous human prostatic tissue. Cancer Res. 37: 4120, 1977.
Foti AG, et al.: Detection of prostatic cancer by solid-phase radio-immunoassay of serum prostatic acid phosphatase. N Engl J Med 297: 1357, 1977.
Foti AG, et al.: Counterimmunoelectrophoresis in determination of prostatic acid phosphatase in human serum. Clin Chem 24: 140, 1978.
Franks LM: The natural history of prostatic cancer. Prog Clin Biol Res 6: 203 1976.
Frick J: Surgical and hormonal therapy of prostatic carcinoma. J Wien Med Wochenschr 127: 480, 1977.
Frick J, et al.: Hormonal status in prostatic disease. Prog Clin Biol Res 6: 143, 1976.
Frick J, et al.: Prostatitis: congestion, T-mycoplasma infection. Prog Clin Biol Res 6: 405, 1976.
Frost P, et al.: An isotope release cytotoxicity assay applicable to human tumors: the use of illindium. Oncology 34: 102. 1977.
Gaeta JF et al.; Scanning electron microscopic study of prostatic cancer. Cancer Treat Rep 61: 277, 1977.
Geder L et al.: Cytomegalovirus and cancer of the prostate: in vitro transformation of human cells. Cancer Treat Rep 61: 139, 1977.
Geller J et al.: Using antiandrogen therapy in benign prostatic hypertrophy. Geriatrics 32: 63, 1977.
Gerard GF et al.: Detection in human ovary and prostate tumors of DNA polymerase activity that copies poly(2’-o-methylcytidylate) oligodeoxyguanylate. Cancer Res 28: 1008, 1978.
Ghanadian R et al.: The use of methyltrienolone in the measurement of the free and bound cytoplasmic receptors for dihydrotestosterone in benign hypertrophied human prostate. J Steroid Biochem 9: 325, 1978.
Gibbons RP et al.: Prostatic carcinoma. Relationship between primary tumor, histologic grade, and response to chemotherapy. Urology 8: 222, 1976.
Goerttler K et al.: Monodispersal and deoxyribonucleic acid analysis of prostatic cell nuclei. J Histochem Cytochem 25: 560, 1977.
Goerttler U: Prostatic gland arteriography. Vascular supply, diagnosis and differential diagnosis of adenoma and carcinoma of the prostate. Radiologe 17: 256. 1977.
Grayhack JT et al.: Lactate dehydrogenase isoenzymes in human prostatic fluid: an aid in recognition of malignancy? J Urol 118: 204, 1977.
Greene LF et al.: Primary transitional cell carcinoma of the prostate. J Urol 116: 761, 1976.
Greene LF; Selection patients for transurethral prostatic resection. Geriatrics 33: 55, 1978.
Gregoir W: Haemostatic prostatic adenomectomy. Eur Urol 4: 1, 1978.
Gustafson A et al.: Treatment of oral estramustine phosphate (Estracyt) in prostatic carcinoma: influences on lipid and carbohydrate metabolism. Invest Urol 15: 220, 1977.
Gustafsson J A et al.: Demonstration of a progestin receptor in human benign prostatic hyperplasia and prostatic carcinoma. Invest Urol 15: 361, 1978.
Habib FE et al.: Metal-androgen interrelationships in carcinoma and hyperplasia of the human prostate. J Endocrinol 71: 133, 1976.
Habib FK et al.: Androgen levels in the plasma and prostatic tissues of patients with benign hypertrophy and carcinoma of the prostate. J Endocrinol 71: 99, 1976.
Hallemans E et al.: Transrectal ultrasono-tomography. Eur Urol 3: 37, 1977.
Hammond GL: Endogenous steroid levels in the human prostate from birth to old age: a comparison of normal and diseased tissues. J Endocrinol 78: 7, 1978.
Hampel N et al.: Primary lymphosarcoma of prostate. Urology 9: 461, 1977.
Handelsman H: The limitations of model systems in prostatic cancer. H Oncology 34: 96, 1977.
Hara S et al.: Prostatic caruncle: a urethral papillary tumor derived from prolapse of the prostatic duct. J Urol 117: 303, 1977.
Harada M et al.: Preliminary studies of histologic prognosis in cancer of the prostate. Cancer Treat Rep 61: 223, 1977.
Haschek H: Cryosurgery of prostate adenoma: evaluation of the method. Prog Clin Biol Res 6: 80, 1976.
Hawkins EF et al.: Steroid receptors in the human prostate. Detection of tissue-specific androgen binding in prostate cancer. Clin Chem Acta 75: 303, 1977.
Heaney JA et al.: Prognosis of clinically undiagnosed prostatic carcinoma and the influence of endocrine therapy. J Urol 118: 283, 1977.
Hellman L et al.: The effect of flutamide on testosterone metabolism and the plasma levels of androgens and gonadotropins. J Clin Endocrinol Metab 45: 1224, 1977.
Hensle TW et al.; Minocycline diffusion into benign prostatic hyperplasia. J Urol 118: 609, 1977.
Herbert JT et al.: Herpes simplex virus type 2 and cancer of the prostate. J Urol 116: 611, 1976.
Herr HW: Immunologic reactivity of lymph nodes regional to prostatic cancer: preliminary observations. J Surg Oncol 9: 509, 1977.
Herr HW: Immune reactivity of lymph nodes regional to prostatic cancer. J Surg Res 24: 409, 1978.
Herr HW et al.: Rectal invasion by benign prostatic hyperplasia. J Urol 118: 497, 1977.
Higuchi M: On the significance of sex hormones in producing experimental prostate tumor in the rat. Recent Results Cancer Res 60; 27, 1977.
Hoag G et al.: The production of creatine kinase isozyme BB in sera of a patient with prostatic carcinoma and in tumor homogenates. Clin Biochem 11: 38, 1978.
Hodgson NB: Long term survival from Müllerian duct carcinoma. Trans Am Assoc Genitour Surg 67: 94, 1975.
Hofstetter A: Tumor classification according to the TNM system in the region of the urogenital tract. 3. Prostatic neoplasma. A Fortschr Med 96: 1066, 1978.
Hohenfeller R: Prostatic carcinoma. Therapeutic concept. Med Welt 29: 1189, 1978.
Hollenberg GM: Extraosseous multiple myeloma simulating prostatic neoplasm. J Urol 119: 292, 1978.
Holmes EJ: Crystalloids of prostatic carcinoma: relationship to Bence-Jones crystals. 39: 2073, 1977.
Holmes FF et al.: Cancer data service. Prostate carcinoma distantly metastatic at diagnosis, 1945–1974. J Kans Med Soc 78: 423, 1977.
Houghton AL et al.: Melphalan in advanced prostatic cancer: a pilot study. Cancer Treat Rep 61: 923, 1977.
Houghton AL et al: Sex hormone binding globulin in carcinoma of the prostate. Br J Urol 49: 227, 1977.
Houghton AL et al.: Advanced carcinoma of the prostate. Does the pretreatment Leydig cell function determine the response to orchidectomy? Postgrad Med J 54: 261, 1978.
Ishibe T: Liver function in prostatic carcinoma patients. Int Urol Nephrol 8: 135, 1976.
Ishibe T: Prognostic usefulness of serum lactic dehydrogenase and its fifth isoenzyme levels in carcinoma of the prostate. Int Urol Nephrol 8: 221, 1976.
Ishibe T: Alterations of serum lactic dehydrogenase and its isoenzyme V fraction levels following hyperglycemic condition in patients with genitourinary neoplasms. Urol Int 32: 393, 1977.
Ishimaru T et al.: Altered metabolism of androgens in elderly men with benign prostatic hyperplasia. J Clin Endocrinol Metab 45: 695, 1977.
Ito TY et al.: Adenocarcinoma of the prostate in paraplegics. Paraplegia 14: 101, 1976.
Jacobi GH et al.: Bromocriptine and prostatic carcinoma: plasma kinetics, production and tissue uptake of 3H-testosterone in vivo. J Urol 119: 240, 1978.
Jacobo E et al.: Comparison of flutamide (SCH-13521) and diethylstilbestrol in untreated advanced prostatic cancer. Urology 8: 231, 1976.
Jacobs SC et al.: Effects of immunosuppression on the rejection of methylcholanthrene tumor isografts. J Surg Oncol 9: 353, 1977.
Jakubik J et al.: Application of silicone implants in plastic surgery in Czechoslovakia.
Jameson RM: Regression of penile mestastases of prostatic carcinoma with cyproterone acetate therapy. Br J Urol 48: 268, 1976.
Javadpour N et al.: Common antigens found on fetal cells and viral transformed adult prostatic tissue. J Surg Oncol 10: 245, 1978.
Jobsis AC et al.: Demonstration of the prostatic origin of metastases: an immunohistochemical method for formalin-fixed embedded tissue. Cancer 41: 1788, 1978.
Johansson H: Chemical sympathectomy with phenol for chronic prostatic pain. Eur Urol 2: 98, 1976.
Johnson DE et al.: National randomized study of chemotherapeutic agents in advanced prostatic carcinoma: a progress report. Cancer Treat Rep 61: 317, 1977.
Johnson DE et al.: Phosphorus-32 for intractable pain in carcinoma of prostate. Analysis of androgen priming, parathormone rebound and combination therapy. Urology 9: 137, 1977.
Jonsson G et al.: Treatment of advanced prostatic carcinoma with estramustine phosphate. Scand J Urol Nephrol 11: 231, 1977.
Jordan WP Jr et al.: Reconsideration of orchiectomy in the treatment of advanced prostatic carcinoma. South Med J 70: 1411. 1977.
Kadohama N et al: 5alpha-Reductase as a target enzyme for antiprostatic drugs in organ culture. Oncology 34: 123, 1977.
Kadohama N et al.:Estramustine phosphate: metabolic aspects related to its action in prostatic cancer. J Urol 119: 234, 1978.
Kambal A; Prostatic obstruction in Sudan. Br J Urol 49: 139, 1977.
Kane RD et al.: Serial carcinoembryonic antigen assays in patients with metastatic carcinoma of prostate being treated with chemotherapy. Urology 8: 559, 1976.
Kane RD et al.: Multiple drug chemotherapy regimen for patients with hormonally-unresponsive carcinoma of the prostate: a preliminary report. J Urol 117: 401, 1977.
Kane RD et al.: Radioisotope bone scanning characteristics of metastatic skeletal deposits of prostatic adenocarcinoma. J Urol 117: 618, 1977.
Khan R et al.: Bone marrow acid phosphatase: another look. J Urol 117: 79, 1977.
King DG et al.: Embryonal rhabdomyosarcoma of the prostate. J Urol 117: 88, 1977.
Kirchheim D: A critical review of histochemical and electromicroscopical studies of total prostatectomy specimens. Prog Clin Biol Res 6: 357, 1976.
Kjeldsberg CR et al.: A qualitative and quantitative study of monocytes in patients with malignant solid tumors. Cancer 41: 2236. 1978.
Kline TS et al.: Prostatic carcinoma and needle aspiration biopsy. Am J Clin Pathol 67: 131, 1977.
Kodama T et al.: Androphilic proteins in cytosols of human benign prostatic hypertrophy. Endocrinol Jpn 24: 565, 1977.
Kongtawng T et al.: Radiographic evaluation of treatment of advanced carcinoma of the prostate. South Med J 71: 247, 1978.
Kopper B et al.: Therapy of prostatic carcinoma. Dtsch Med Wochenschr 102: 1423, 1977.
Krarup T et al.: Prostatic carcinoma treated with 2,6-cis- diphenylhexamethylcyclotetrasiloxane (Cisobitan). Scand J Urol Nephrol 12: 11, 1978.
Krieg M et al.: Quantification of androgen binding, androgen tissue levels, and sex hormone-binding globulin in prostate, muscle and plasma oi patients with benign prostatic hypertrophy. Acta Endocrinol (Kbh) 86: 300, 1977.
Krieg M et al.: Human prostatic carcinoma: significant differences in its androgen binding and metabolism compared to the human benign prostatic hypertrophy. Acta Endocrinol (Kbh) 88: 397, 1978.
Kuss R et al.: The effect of transurethral resection of the prostate on lymphocyte response in patients with prostatic cancer. J Urol 120: 388, 1978.
Kvols LK et al.: Evaluation of melphalan, ICRF-159, and hydroxyurea in metastatic prostate cancer: a preliminary report. Cancer Treat Rep 61: 311, 1977.
Kwart AM et al.: Blood vascular invasion: a poor prognostic factor in adenocarcinoma of the prostate. J Urol 119: 138, 1978.
Landes RR et al.: Effect of preoperative antibiotic therapy on bacterial prostatitis after transurethral prostatectomy. Urology 8: 352, 1976.
Landgarten S et al.: Hypercalcemia corrected by orchiectomy in a patient with carcinoma of the prostate. J Okla State Med Assoc 71: 288, 1978.
Lapides J: Prostatitis. Prog Clin Biol Res 6: 363, 1976.
Lasintzki I: Reversal of methylcholanthrene-induced changes in mouse prostates in vitro by retinoic acid and its analogues. Br J Cancer 34: 239, 1976.
Lee CI et al.: A solid-phase fluorescent immunoassay for human prostatic acid phosphatase. Cancer Res 28: 2871, 1978.
Lee LW et al.: Granulomatous prostatitis. Association with isolation of Mycobacterium kansasii and Mycobacterium fortuitum. JAMA 237: 2408, 1977.
Leisering W: Therapeutic and prognostic aspects of cancer of the prostate detected incidentally in the course of adenoma enucleation. W Int Urol Nephrol 10: 23, 1978.
Lerner HJ et al.: Hydroxyurea in stage D Carcinoma of prostate. Urology 10: 35, 1977.
Levin AB et al.: Chemical hypophysectomy for relief of bone pain in carcinoma of the prostate. J Urol 119: 517, 1978.
Lin JI et al.: Basal cell adenoma of prostate. Urology 11: 409, 1978.
Lipsett JA et al.: Factors influencing prognosis in the radiotherapeutic management of carcinoma of the prostate. Int J Radiat Oncol Biol Phys 1: 1049, 1976.
Little C et al.: Bone marrow acid phosphatase concentrations in individuals with prostatic carcinoma or other disorders. Can Med Assoc J 119: 259, 1978.
Lo MC et al.: Metastatic prostatic adenocarcinoma of male breast. Urology 11: 641, 1978.
Loening SA et al.: A comparison between lymphangiography and pelvic node dissection in the staging of prostatic cancer. J Urol 117: 752, 1977.
Lopez DM et al.: Adenocarcinoma R-3327 of the Copenhagen rat as a suitable model for immunological studies of prostate cancer. Cancer Res 37: 2057, 1977.
Louis JF et al.: Contribution of osseous scintigraphy in the determination of metastases of cancer of the prostate. J Urol Nephrol 82 Suppl 2: 459, 1976.
Lubaroff DM et al.: R3327 adenocarcinoma of the Copenhagen rat as a model for the study of the immunologic aspects of prostate cancer. J Natl Cancer Inst 58: 1677, 1977.
Madduri SD et al.: Biologic and pathophysiologic prognosticating indices in prostatic cancer. Am Surg 44: 290, 1978.
Mainwarin WI: The relevance of studies on androgen action to prostatic cancer. Curr Top Mol Endocrinol 4: 152, 1976.
Markland FS et al.: Characterization of steroid hormone receptors in the Dunning R-3327 rat prostatic adenocarcinoma. Cancer Res 38: 2818, 1978.
Mathes GL et al.: An alternative to radical surgery for cancer of the prostate. Geriatrics 33: 53, 1978.
Mawhinney MG et al.: Androgens and estrogens in prostatic neoplasia. Adv Sex Horm Res 2: 141, 1976.
McCombs RM: Role of oncornaviruses in carcinoma of the prostate. Cancer Treat Rep 61: 131, 1977.
McDuffie RW Jr et al.: Radical retropubic prostatectomy: 59 cases. J Urol 119: 514, 1978.
McGowan DG: Radiation therapy in the management of localized carcinoma of the prostate: a preliminary report. Cancer 39: 98, 1977.
McMillen SM et al.: The role of repeat transurethral biopsy in stage A carcinoma of the prostate. J Urol 116: 759, 1976.
McNeal JE: Origin and evolution of benign prostatic enlargement. Invest Urol 15: 340, 1978.
McRoberts JW et al.: Carcinoma of the prostate. J Ky Med Assoc 76: 127, 1978.
Merino MJ et al.: Penile Paget’s disease and prostatic carcinoma. J Urol 120: 121, 1978.
Merrin C: Treatment of advanced carcinoma of the prostate (stage D) with infusion of cisdiammin-edichloroplatinum (II NSC-119875): a pilot study. J Urol 119: 522, 1978.
Merrin C et al.: The clinical value of lymphangiography: are the nodes surrounding the obturator nerve visualized? J Urol 117: 762, 1977.
Michigan S et al.: Ureteral obstruction from prostatic carci-noma: response to endocrine and radiation therapy. J Urol 118: 733, 1977.
Mickey DD et al.: Morphologic and immunologic studies of human prostatic carcinoma. Cancer Treat Rep 61: 133, 1977.
Migdalska B et al.: Serum levels and urine excretion of corticoids in patients with prostatic hypertrophy. Endokrynol Pol 28: 53, 1977.
Mittelman A et al.: New steroidal alkylating agents in advanced stage D carcinoma of the prostate. Cancer Treat Rep 61: 307, 1977.
Mobbs BG et al.: Androgen receptor assay in human benign and malignant prostatic tumor cytosol using protamine sulphate precipitation. J Steroid Biochem 9: 289, 1978.
Moller JT: Transrectal cytological aspiration biopsy in prostatic disease. Int Urol Nephrol 9: 235, 1977.
Morfin RF et al.: Correlative study of the morphology and CI 9-steroid metabolism of benign and cancerous human prostatic tissue. Cancer 29: 1517, 1977.
Morfin RF et al.: Precursors for 6beta-and 7 alpha-hydroxyl- ations of 5alpha-androstane-3beta, 17beta-diol by human normal and hyperplastic prostates. Biochimie 59: 637, 1977.
Morfin RF et al.: Comparison of testosterone, 5alpha-dihydro-testosterone and 5alpha-adrostane-3beta, 17beta-diol metabolisms in human normal and hyperplastic prostates. J Steroid Biochem 3: 345, 1978.
Morganstern S et al.: Large prostatic hematomas associated with carcinoma of the prostate. J Urol 117: 622, 1977.
Morin ME et al.: Lymphocele: a complication surgical staging of carcinoma of the prostate. AJR 129: 333, 1977.
Muntzing J et al.: Enzyme activity and distribution in rat prostatic adenocarcinoma. Urology 11: 278, 1978.
Murphy GP: Chemotherapy of advanced prostatic cancer. Rev Surg 34: 75, 1977.
Murphy GP et al.: Prostatic cancer; evolution of treatment at a comprehensive center (1970–1974). Urology 8: 357, 1976.
Murphy GP et al.: Chemotherapy of advanced prostatic cancer today. Prog Clin Biol Res 6: 285, 1976.
Murphy GP et al.: A comparison of estramustine phosphate and streptozotocin in patients with advanced prostatic carcinoma who have had extensive irradiation. J Urol 118: 288, 1977.
Nachtsheim DA Jr et al.: Latent residual tumor following external radiotherapy for prostate adenocarcinoma. J Urol 120: 312, 1978.
Nagel R: Therapeutic concept in prostatic adenoma. Med Welt 29: 1194, 1978.
Nagel R et al.: Treatment of advanced carcinoma of the prostate with Estracyt. Prog Clin Biol Res 6: 267, 1976.
Nagel R et al.: Treatment of advanced carcinoma of the prostate with estramustine phosphate. Br J Urol 49: 73, 1977.
Naik KG: Patterns of tumors of the male genitalia in Zambia. Int Surg 62: 356, 1977.
Narayana AS et al.: Sarcoma of the bladder and prostate. J Urol 119: 72, 1978.
Neglia WJ et al.: Mega voltage radiation therapy for carcinoma of the prostate. Int J Radiat Oncol Biol Phys 2: 873, 1977.
Neumann R et al.: Antiandrogens and prostatic tumors (experimental base and clinical use). Prog Clin Biol Res 6: 169, 1976.
Nicholson TC et al.: Pelvic lymphadenectomy for stage B1 adenocarcinoma or the prostate: justified or not? J Urol 117: 199, 1977.
Nicolescu D et al.: Improved suprapubic vesical drainage in transvesical prostatectomy. Eur Urol 4: 230, 1978.
Nienhaus H: Aspiration biopsy cytology of prostate carcinoma. H Recent Result Cancer Res 60: 53, 1977.
Nishimura T et al.: Immunoglobulin A in split ejaculates of patients with prostatitis. Urology 9: 186, 1977.
Nissen HM et al.: The prognosis in carcinoma of the prostate, judged on the basis of clinical classification into stages and histological grading. Int Urol Nephrol 9: 17, 1977.
Noble RL: The development of prostatic adenocarcinoma in Nb rats following prolonged sex hormone administration. Cancer Res 37: 1929, 1977.
Noble RL: Sex steroids as a cause of adenocarcinoma of the dorsal prostate in Nb rats, and their influence on the growth of transplants. Oncology 34: 138, 1977.
Nolten WE et al.: The effects of diethylstilbestrol and medroxyprogesterone acetate on kinetics and production of testosterone and dihydrotestosterone in patients with prostatic carcinoma. J Clin Endocrinol Metab 43: 1226, 1976.
O’Donoghue EP et al.: Lymphography and pelvic lymphaden- ectomy in carcinoma of the prostate. Br J Urol 48: 689, 1976.
O’Donoghue EP et al.: Early diagnosis of prostatic carcinoma: the role of transurethral resection. Br J Urol 49: 705, 1977.
Ohtsuki Y et al.: Virus-like particles in a case of human prostate carcinoma. J Natl Cancer Inst 58: 611, 1976.
Ohtsuki Y et al.: Particle-lamella complexes in a case of human benign prostate hyperplasia: brief communication. J Natl Cancer Inst 60: 299, 1978.
Oka M et al.: Endocrine therapy and serum urinary testosterone levels, as a monitoring, in patients with carcinoma of the prostate. Nippon Gan Chiryo Gakkai Shi 12: 336, 1977.
Olsson AM et al.: Advanced cancer of the prostate combined with hypercalcaemia. Scand J Urol Nephrol 11: 293, 1977.
Owen WL et al.: Health services delivery to prostatic cancer patients. J Okla State Med Assoc 70: 436, 1977.
Palanca E et al.: Conservative treatment of benign prostatic hyperplasia. Curr Med Res Opin 4: 513, 1977.
Pasqualucci V et al.: Result of hypophyseal neuroadenolysis in a 1st group of cancer patients. Minerva Anestes 44: 263, 1978.
Paul BD et al.: New agents for prostatic cancer activated specifically by prostatic acid phosphatase. Cancer Treat Rep 61: 259, 1977.
Peison B et al.: Acute urinary obstruction secondary to pseudolymphoma of prostate. Urology 10: 478, 1977.
Perez CA: Radiation therapy in the management of carcinoma of the prostate. Curr Probi Cancer 1: 30, 1976.
Perlstein GB: Case profile: ectopic bone formation in prostatic carcinoma. Urology 11: 651, 1978.
Pervaiz N et al.: Cutaneous metastases from prostatic carcinoma. Urology 11: 403, 1978.
Petersen DS et al.: Biopsy and clinical course after cryosurgery for prostatic cancer. J Urol 120: 308, 1978.
Pfau A et al.: Chronic bacterial prostatitis: new therapeutic aspects. J Urol 48: 245, 1976.
Pietila J et al.: Weight, stroma to gland ratio, and mitotic activity of the human hyperplastic prostate. Inves Urol 15: 90, 1977.
Pollard M: Animal model of human disease: metastic adenocarcinoma of the prostate. Am J Pathol 86: 277, 1977.
Pollard M et al.: Investigations on prostatic adenocarcinomas in rats. Oncology 34: 129, 1977.
Pond HS et al.: Defense of the radical perineal prostatectomy. South Med J 71: 541, 1978.
Pontes JE et al.: Indirect immunofluorescence for identification of prostatic epithelial cells. J Urol 117; 459. 1977.
Potsaid MS et al.: (32P) diphosphonatase determination in patients with bone metastases from prostatic carcinoma. J Nucl Med 19: 98, 1978.
Pretlow TG et al.: Separation and characterization of epithelial cells from prostates and prostatic carcinomas: a review. Cancer Treat Rep 61: 153, 1977.
Prout GR Jr et al.: In vitro uptake of 3H-testosterone and its conversion to dihydrotestosterone by prostatic carcinoma and other tissues. J Urol 116: 603, 1976.
Pytel IuA et al.: Use of supravital staining of the epithelial cells of the urine of prostatic cancer. Lab Delo 2: 80, 1978.
Quinnan GV Jr et al.: Prostatic carcinoma presenting as pericardial tamponade. Cancer Treat Rep 61: 1607, 1977.
Rader ES: Hematologic screening tests in patients with operative prostatic disease. Urology 11: 243, 1978.
Ramzy I et al.: Prostatic duct carcinoma: exfoliative cytology. Acta Cytol 21: 417, 1977.
Rao MS et al.: Multiple urethral metastases from prostatic carcinoma causing urinary retention. Urology 10: 566, 1977.
Ravich A: Point of view-misleading reports on Japanese incidence of prostatic cancer. Urology 11: 542, 1978.
Ray GR: Adenocarcinoma of the prostate: the need for standardized, controlled, prospective trials and less empiricism. Int J Radiat Oncol Biol Phys 2: 1041, 1977.
Reddy AN et al.: Intermittent cholestatic jaundice and nonmetastatic prostatic carcinoma. Arch Intern Med 137: 1616, 1977.
Resnic ME et al.: Recent progress in ultrasonography of the bladder and prostate. J Urol 117: 444, 1977.
Resnick MI et al.: Recent progress in ultrasonography of the bladder and prostate. Trans Am Assoc Genitourin Surg 68: 8, 1976.
Rhodes RH et al.: Malacoplakia of the prostate following chronic urinary tract infection. J Urol 117: 808, 1977.
Robin PE: Major endocrine ablation for carcinoma of the breast and prostate. Clin Otolaryngol 3: 213, 1978.
Robinson MR et al.: Experimental cellular allergic reactions in normal canine and malignant human prostate. Clin Exp Immunol 26: 137, 1976.
Robinson MR et al.: Adjuvant immunotherapy with B.C.G. in carcinoma of the prostate. Br J Urol 49: 221, 1977.
Rotkin ID: Studies in the epidemiology of prostatic cancer; expanded sampling. Cancer Treat Rep 61: 173, 1977.
Rummelhardt S: Prostatic cancer as an incidental finding on prostatectomy. Prog Clin Biol Res 6: 95, 1976.
Sadlowski RW: Early stage prostatic cancer investigated by pelvic lymph node biopsy and bone marrow acid phosphatase. J Urol 119: 89, 1978.
Sandberg AA et al.: Some new approaches to potential test systems for drugs against prostatic cancer. Cancer Treat 61: 289, 1977.
Sande van, M et al.: On the presence of cysteinesulfinic acid and 2-aminoethanesulfinic acid in human adenomatous prostate. Eur Urol 4: 204, 1978.
Sanford EJ et al.: In vitro culture of human prostatic tissue. Urol Res 5: 207, 1977.
Sanford EJ et al.: Evidence for the association of cytomegalovirus with carcinoma of the prostate. J Urol 118: 789, 1977.
Sanford EJ et al.: Humoral and cellular immune response of prostatic cancer patients to cytomegalovirus-related antigens. J Surg Res 24: 404, 1978.
Sanford EJ et al.: The effects of castration on adrenal testosterone secretion in men with prostatic carcinoma. J Urol 118: 1019, 1977.
Scerbakov AP: Objective interpretation of the pneumocystograms on prostata-adenoma. Radiol Diagn 19: 87, 1978.
Schaffer DL et al.: Comparison of enzyme, clinical, radiographic, and radionuclide methods of detecting bone metastases from carcinoma of the prostate. Radiology 121: 431, 1976.
Schirmer HK et al.: Irradiation therapy of stage B and C prostatic cancer mode of action, rationale and clinical results. Prog Clin Biol Res 6: 347, 1976.
Schnorr D et al.: Endocrine effects of oestrogen treatment in patients with prostatic cancer. Eur Urol 2: 85, 1976.
Schroder FH et al.: Prostatic adenoma and carcinoma in cell culture and heterotransplantation. Prog Clin Biol Res 6: 301, 1976.
Schwarz H: Prostatitis. Prog Clin Biol Res 6: 365, 1976.
Scott MB et al.: Papillary adenocarcinoma of prostate. Urology 8: 227, 1976.
Scott WW et al: The continued evaluation of the effects of chemotherapy in patients with advanced carcinoma of the prostate. Trans Am Assoc Genitourin Surg 68: 24, 1976.
Shain SA et al.: C19-steroid metabolism by spontaneous adenocarcinoma of the AXC rat ventral prostate. J Natl Cancer Inst 58: 747, 1977.
Shain SA et al.: Androgen receptor content of the normal and hyperplastic canine prostate. J Clin Invest 61: 654, 1978.
Shain SA et al.: Characterization of unoccupied (R) and occupied (RA) androgen binding components of the hyperplastic human prostate. Steroids 31: 541, 1978.
Shiraiwa Y et al.: Freezing index in cryosurgery on the prostate gland. Tohoku J Exp Med 123: 49, 1977.
Silverton NP: Testicular metastasis from prostatic carcinoma. Br J Urol 48: 498, 1976.
Sinha AA et al: Freeze-fracture observations on the membranes and junctions in human prostatic carcinoma and benign prostatic hypertrophy. Cancer 40: 1182, 1977.
Sinha AA et al.: A critical analysis of tumor morphology and hormone treatments in the untreated and estrogen-treated responsive and refractory human prostatic carcinoma. Cancer 40: 2836, 1977.
Sinowatz F et al.: A histochemical study of glycosidases in benign prostatic hyperplasia and in prostatic carcinoma in the human. Urol Res 6: 103, 1978.
Sirett DA et al.: Androgen binding in cytosol and nucleus of cells from human benign hyperplastic prostate. J Endocrinol 75: 25P, 1977.
Sirett DA et al.: Androgen binding in cytosols and nuclei of human benign hyperplastic prostatic tissue. J Endocrinol 77: 101, 1978.
Smolev JK et al.: Characterization of the Dunning R 3327H prostatic adenocarcinoma: an appropriate animal model for prostatic cancer. Cancer Treat Rep 61: 273, 1977.
Smolev JK et al.: Experimental models for the study of prostatic adenocarcinoma. J Urol 118: 216, 1977.
Smyth PP et al.: Effect of stilboesterol therapy on thyrotrophin-releasing hormon (TRH) responsiveness in males. Clin Endocrinol 1: 139, 1977.
Snochowski M et al.: Characterization and measurement of the androgen receptor in human benign prostatic hyperplasia and prostatic hyperplasia and prostatic carcinoma. J Clin Endocrinol Metab 45: 920, 1977.
Sonnenschein R: The effectiveness of transrectal aspiration cytology in the diagnosis of prostatic cancer. Eur Urol 1: 189, 1975.
Spaulding JT et al.: Extended total excision of prostatic adenocarcinoma. J Urol 120: 188, 1978.
Sprenger E et al.: The significance of DNA flow-through fluorescence cytophotometry for the diagnosis of prostate carcinoma. Beitr Pathol 159: 292, 1976.
Stallwood G et al.: Leiomyosarcoma of the rectum and prostate. Can J Surg 20: 446, 1977.
Staquet M: The randomized clinical trial: a prerequisite for rational therapy. Eur Urol 2: 265, 1976.
Steg A et al.: Recurrent benign prostatic hypertrophy. Prog Clin Biol Res 6: 81, 1976.
Stone KR et al.: Isolation of a human prostate carcinoma cell line (DU 145). Int J Cancer 21: 274, 1978.
Stone MP et al.: Scanning and transmission electron microscopy of human prostatic acinar cells. Urol Res 5: 185, 1977.
Sweitzer S et al.: Carcinoma of the prostate diagnosed initially as carcinoma of the rectum. Am Surg 43: 751, 1977.
Szymanoski J et al.: Study of the interdependence between prostatic hypertrophy and disorders in hormone levels. 1. Study of blood testosterone. J Urol Nephrol 82: 827, 1976.
Taylor EW et al.: Granulomatous prostatitis: confusion clinically with carcinoma of the prostate. J Urol 117: 316, 1977.
Taylor WK: Radiation oncology: cancer of the prostate. Cancer 39: 856, 1977.
Tejada F et al.: 5-fluorouracil versus CCNU in the treatment of metastatic prostatic cancer. Cancer Treat Rep 61: 1589, 1977.
Tulinius H: Epidemiology of prostate carcinoma. Recent Results Cancer Res 60: 3, 1977.
Van Hoff DD et al.: Estramustine phosphate: a specific chemotherapeutic agent. J Urol 117: 464, 1977.
Vassilakis GB: Pure leiomyoma of prostate. Urology 11: 93, 1978.
Veenema RJ et al.: Bone marrow acid phosphatase: prognostic value in patients undergoing radical prostatectomy. J Urol 117: 81, 1977.
Ventura M et al.: Transrectal prostatic biopsy using Franzen’s needle in the cytologic diagnosis of prostatic cancer. J Urol Nephrol 83: 858, 1977.
Vincente J: Approach of transurethral adenomectomy: diagnosis and therapy. J Eur Urol 3: 310, 1977.
Wajsman A et al.: Blood group distribution in prostatic cancer patients. J Surg Oncol 9: 289, 1977.
Wajsman Z et al.: Clinical significance of serum alkaline phosphatase isoenzyme levels in advanced prostatic carcinoma. J Urol 119: 244, 1978.
Ward AM et al.: Acute phase reactant proteins in prostatic cancer. Gr J Urol 49: 411. 1977.
Weismann RM et al.: Cell kinetic studies of prostatic cancer: adjuvant therapy in animal models. Oncology 34: 133, 1977.
Welch MJ et al.: Carbon-11-labeled methylated polyamine analogs: uptake in prostate and tumor in animal models. J Nucl Med 18: 74, 1977.
Wenk RE et al.: Ectopic ACTH, prostatic cell carcinoma and marked hypernatremia. Cancer 40: 773, 1977.
Wheeler RR et al.: Use of a caliper to determine dimensions of the volume to be implanted with 125 iodine in the treatment of prostatic carcinoma. J Urol 120: 306, 1978.
Williams RD et al.: Production of carcinomaembryonic antigen by human prostate epithelial cells in vitro. J Natl Cancer Inst 58: 115, 1977.
Wilson CS et al.: Pelvic lymphadenectomy for the staging of apparently localized prostatic cancer. J Urol 117: 197, 1977.
Witherington R: Transvesical prostatic adenomectomy: a modification of Lower, Harris and Hryntschak techniques. Am Surg 43: 330, 1977.
Workman P: Inhibition of human prostatic tumour acid phosphatase by N,N-p-di-2-chloreothylaminophenol, N,N-p-di-2- chloroethylaminophenyl phosphate and other dysfunctional nitrogen mustards. Chem Biol Interact 20: 103, 1978.
Yamamoto KR and BM Alberts: Steroid receptors: Elements for modulation of eukaryotic transcription. Annu Rev Biochem 45: 721, 1976.
Yunda IF et al.: Testosterone excretion in chronic prostatitis. Andrologia 9: 89, 1977.
Zimel H et al.: Scanning of the prostate with Stilbostat-1311. Endocrinologie 15: 127, 1977.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 Martinus Nijhoff Publishers bv, The Hague
About this chapter
Cite this chapter
Hafez, E.S.E. (1981). Epilogue. In: Hafez, E.S.E., Spring-Mills, E. (eds) Prostatic Carcinoma. Clinics in Andrology, vol 6. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-8887-3_16
Download citation
DOI: https://doi.org/10.1007/978-94-009-8887-3_16
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-009-8889-7
Online ISBN: 978-94-009-8887-3
eBook Packages: Springer Book Archive